PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $22,000 | +10.0% | 4,729 | 0.0% | 0.01% | -12.5% |
| Q4 2018 | $20,000 | -23.1% | 4,729 | +10.5% | 0.01% | -27.3% |
| Q3 2018 | $26,000 | -25.7% | 4,279 | -1.2% | 0.01% | -26.7% |
| Q2 2018 | $35,000 | +12.9% | 4,329 | 0.0% | 0.02% | +15.4% |
| Q1 2018 | $31,000 | +72.2% | 4,329 | +50.4% | 0.01% | +62.5% |
| Q4 2017 | $18,000 | -14.3% | 2,878 | +0.9% | 0.01% | -20.0% |
| Q3 2017 | $21,000 | +250.0% | 2,852 | +226.7% | 0.01% | +233.3% |
| Q2 2017 | $6,000 | -25.0% | 873 | -0.3% | 0.00% | -25.0% |
| Q1 2017 | $8,000 | 0.0% | 876 | -4.6% | 0.00% | 0.0% |
| Q4 2016 | $8,000 | – | 918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 1,255,000 | $5,823,000 | 1.12% |
| Phocas Financial Corp. | 1,146,292 | $5,319,000 | 0.54% |
| Worth Venture Partners, LLC | 138,357 | $641,000 | 0.36% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,293,179 | $10,640,000 | 0.34% |
| Monashee Investment Management LLC | 240,000 | $1,114,000 | 0.26% |
| BKS ADVISORS, LLC | 118,587 | $550,000 | 0.22% |
| PINNACLE ASSOCIATES LTD | 1,418,391 | $6,581,000 | 0.15% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,200,820 | $19,492,000 | 0.15% |
| Fosun International Ltd | 472,580 | $2,174,000 | 0.14% |
| CARILLON TOWER ADVISERS, INC. | 3,948,024 | $18,318,000 | 0.13% |